본문 바로가기
KERD
논문KCI 등재

Tusc2/Fus1 regulates osteoclast differentiation through NF-kB and NFATc1

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류화학

초록

Tumor suppressor candidate 2 (Tusc2, also known as Fus1) regulates calcium signaling, and Ca2+-dependent nuclear factor of activated T-cells (NFAT) and nuclear factor kappa B (NF-kB) pathways, which play roles in osteoclast differentiation. However, the role of Tusc2 in osteoclasts remains unknown. Here, we report that Tusc2 positively regulates the differentiation of osteoclasts. Overexpression of Tusc2 in osteoclast precursor cells enhanced receptor activator of nuclear factor kB ligand (RANKL)-induced osteoclast differentiation. In contrast, small interfering RNA-mediated knockdown of Tusc2 strongly inhibited osteoclast differentiation. In addition, Tusc2 induced the activation of RANKL-mediated NF-kB and calcium/calmodulin-dependent kinase IV (CaMKIV)/ cAMP-response element (CRE)-binding protein CREB signaling cascades. Taken together, these results suggest that Tusc2 acts as a positive regulator of RANKL-mediated osteoclast differentiation.

Abstract

Tumor suppressor candidate 2 (Tusc2, also known as Fus1) regulates calcium signaling, and Ca2+-dependent nuclear factor of activated T-cells (NFAT) and nuclear factor kappa B (NF-kB) pathways, which play roles in osteoclast differentiation. However, the role of Tusc2 in osteoclasts remains unknown. Here, we report that Tusc2 positively regulates the differentiation of osteoclasts. Overexpression of Tusc2 in osteoclast precursor cells enhanced receptor activator of nuclear factor kB ligand (RANKL)-induced osteoclast differentiation. In contrast, small interfering RNA-mediated knockdown of Tusc2 strongly inhibited osteoclast differentiation. In addition, Tusc2 induced the activation of RANKL-mediated NF-kB and calcium/calmodulin-dependent kinase IV (CaMKIV)/ cAMP-response element (CRE)-binding protein CREB signaling cascades. Taken together, these results suggest that Tusc2 acts as a positive regulator of RANKL-mediated osteoclast differentiation.

참고문헌 (34)

  1. Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
  2. Walsh MC, "Osteoimmunology: interplay between the immune system and bone metabolism", Annu Rev Immunol, 24, pp.33~63 (2006)
  3. Teitelbaum SL, "Bone resorption by osteoclasts", Science, 289, pp.1504~1508 (2000)
  4. Ogasawara T, "Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6", Mol Cell Biol, 24, pp.6560~6568 (2004)
  5. 김정하, "Signaling Pathways in Osteoclast Differentiation", 전남의대학술지, 52(1), pp.12~17 (2016), 의과학연구소
  6. 김정하, "Regulation of NFATc1 in Osteoclast Differentiation", 대한골대사학회지, 21(4), pp.233~241 (2014), 대한골대사학회[DOI]
  7. Kim K, "Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis", J Biol Chem, 280, pp.35209~35216 (2005)
  8. Kim K, "NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP)", Mol Endocrinol, 22, pp.176~185 (2008)
  9. Takayanagi H, "Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell, 3, pp.889~901 (2002)
  10. Hwang SY, "Calcium signaling in osteoclasts", Biochim Biophys Acta, 1813, pp.979~983 (2011)
  11. Hogan PG, "Transcriptional regulation by calcium, calcineurin, and NFAT", Genes Dev, 17, pp.2205~2232 (2003)
  12. Racioppi L, "Calcium", calmodulindependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller, 2008, pp.29, 600~607
  13. Sato K, "Regulation of osteoclast differentiation and function by the CaMK-CREB pathway", Nat Med, 12, pp.1410~1416 (2006)
  14. Ang ES, "Calcium", calmodulindependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL), 2007, pp.212, 787~795
  15. Krueger JK, "Structures of calmodulin and a functional myosin light chain kinase in the activated complex: a neutron scattering study", Biochemistry, 36, pp.6017~6023 (1997)
  16. Prudkin L, "Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer", Clin Cancer Res, 14, pp.41~47 (2008)
  17. Ivanova AV, "Mechanisms of FUS1", TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects, 2009, pp.8, 91~
  18. Li G, "Frequent absence of tumor suppressor FUS1 protein expression in human bone and soft tissue sarcomas", Anticancer Res, 31, pp.11~21 (2011)
  19. Uzhachenko R, "Fus1", Tusc2 is a novel regulator of mitochondrial calcium handling, Ca2+- coupled mitochondrial processes, and Ca2+-dependent NFAT and NF-kappaB pathways in CD4+ T cells, 2014, pp.20, 1533~1547
  20. Kim K, "Pim-1 regulates RANKL-induced osteoclastogenesis via NF-kappaB activation and NFATc1 induction", J Immunol, 185, pp.7460~7466 (2010)
  21. Kajiya H, "Calcium signaling in osteoclast differentiation and bone resorption", Adv Exp Med Biol, 740, pp.917~932 (2012)
  22. Uzhachenko R, "Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity", Oncotarget, 6, pp.20754~20772 (2015)
  23. Takami M, "Ca2+-ATPase inhibitors and Ca2+-ionophore induce osteoclast-like cell formation in the cocultures of mouse bone marrow cells and calvarial cells", Biochem Biophys Res Commun, 237, pp.111~115 (1997)
  24. Franzoso G, "Requirement for NF-kappaB in osteoclast and B-cell development", Genes Dev, 11, pp.3482~3496 (1997)
  25. Takatsuna H, "Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1", J Bone Miner Res, 20, pp.653~662 (2005)
  26. Asagiri M, "Autoamplification of NFATc1 expression determines its essential role in bone homeostasis", J Exp Med, 202, pp.1261~1269 (2005)
  27. Dolmetsch RE, "Differential activation of transcription factors induced by Ca2+ response amplitude and duration", Nature, 386, pp.855~858 (1997)
  28. Lilienbaum A, "From calcium to NF-kappa B signaling pathways in neurons", Mol Cell Biol, 23, pp.2680~2698 (2003)
  29. Tabary O, "Calciumdependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells", Cell Signal, 18, pp.652~660 (2006)
  30. Boland ML, "Mitochondrial dysfunction in cancer", Front Oncol, 3, pp.292~ (2013)
  31. Brendan F. Boyce, "NF-κB-Mediated Regulation of Osteoclastogenesis", Endocrinology and Metabolism, 30(1), pp.35~44 (2015), 대한내분비학회
  32. Park HJ, "The cooperation of CREB and NFAT is required for PTHrPinduced RANKL expression in mouse osteoblastic cells", J Cell Physiol, 230, pp.667~679 (2015)
  33. Kim K, "MafB negatively regulates RANKL-mediated osteoclast differentiation", Blood, 109, pp.3253~3259 (2007)
  34. 송인선, "GATA4 negatively regulates bone sialoprotein expression in osteoblasts", BMB Reports, 49(6), pp.343~348 (2016), 생화학분자생물학회

관련 논문AI추천

이 간행물의 다른 논문 (7건)